Hamilton, S H <br/><br/>
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  Jan 1998 
 - 41-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0893-133X 
<br/><br/><label>Standard No.: </label>10.1016/S0893-133X(97)00111-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antipsychotic Agents--therapeutic use<br/>Benzodiazepines<br/>Double-Blind Method<br/>Female<br/>Haloperidol--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Olanzapine<br/>Pirenzepine--analogs & derivatives<br/>Psychiatric Status Rating Scales<br/>Quality of Life<br/>Schizophrenia--drug therapy<br/>Schizophrenic Psychology<br/>Treatment Outcome